InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Features of Swiss-type claims

Managing Intellectual Property


Methods for the diagnosis or treatment of diseases can receive protection in China if presented in a Swiss-type claim. Liantao Li and Tina H. Tai from China Patent Agent (HK) explain this process

Methods for the diagnosis or treatment of diseases are subject matters excluded from patentability in all nations except a few countries such as the US. In most nations and regions such as Europe, Japan and China, however, protection has been made available for new medical or pharmaceutical uses of known compounds/compositions if presented in a Swiss-type claim. This has also been expanded to protect new dosage regimens of known medicaments in Europe.

In response to such an expansion, the Chinese Patent Office (CPO) takes a very conservative position. For example, in its office actions, the CPO typically comments as the following: "A daily dose of 10mg and oral dosing are both an administration feature of a medicament. As a general rule, such a feature of administration per se does not serve as a definition of, or limitation on, a technical solution of any process/use for preparing the medicament".


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Come to booth #1320 at #inta15 to get your copy of our new Gray Market Strategy map, produced with @bakermckenzie http://t.co/dSOEY1kXqe

Apr 27 2015 05:14 ·  reply ·  retweet ·  favourite
ManagingIP profile

2 immediate questions on Google's Patent Purchase Promotion: how much money do they have to spend? Will they try to enforce them?

Apr 27 2015 02:29 ·  reply ·  retweet ·  favourite
ManagingIP profile

@PrisonPlanet Would need to ask an IP lawyer to interpret the agreement. Similar Ts & Cs seem to be becoming commonplace.

Apr 27 2015 02:26 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


AIPLA Daily Report 2014

Read this year's AIPLA Daily Report - published daily by Managing IP direct from the AIPLA Annual Meeting in Washington DC


null null null

May 2015

The voices of IP - from 1990 to 2015

Over the past 25 years, Managing IP has interviewed most of the influential people in IP.



Most read articles

Supplements